Barely Significant
← all excerpts

Personalized CFTR Modulator Therapy for <i>G85E</i> and <i>N1303K</i> Homozygous Patients with Cystic Fibrosis.

Int J Mol Sci · 2023 · PMC10418744 · PMID 37569738

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
The basal short circuit current (I sc ), amiloride-sensitive I sc and amiloride-insensitive I sc were not significantly different between vehicle control and ETI treatment in cultures derived from the G85E / G85E patient, although amiloride-sensitive I sc showed a trend towards a decrease with ETI treatment ( Figure 1 C,E–G).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.